Amgen names senior VP, global regulatory affairs
This article was originally published in Scrip
Amgen has named Dr Steven K Galson senior vice-president, global regulatory affairs and safety – effective 19 May 2014. Dr Galson joined the Thousand Oaks, California-based company in October 2010 as vice-president of global regulatory affairs. Prior to joining Amgen he was senior vice-president for civilian health operations and chief health scientist at Science Applications International Corporation.
You may also be interested in...
Coaching and mentoring are important tools for the leaders of today to be able to foster the next generation of talent in the biopharma sector. While the routes into industry have not changed dramatically – most leaders hold a master’s degree and/or PhD – the expectations of rising leaders have altered and the industry itself has become more collaborative.
Angeli Möller, recently spotlighted by In Vivo as a 2020 Rising Leader, has quickly moved up the ranks at Bayer and is now spearheading one of its key initiatives to bring artificial intelligence and machine learning technologies into the pharma business.
In this first edition of In Vivo's ‘Rising Leaders’ list, the focus is on entrepreneurs and innovators who represent the next wave of creativity in health care.